[6-min read] Q&A with Jonathan Dickinson, Founder & CEO
[3-min read] Psychedelic facilitators share healthy ways to work through strong emotions.
[5-min read] Compass Pathways achieves the primary endpoint in its first Phase 3 trial.
[5-min read] Q&A with Howard Lipp, Metaphysicist & Musician
[3-min read] Facilitators explain how to create new neural pathways while microdosing.
[5-min read] Randomized controlled trial shows cultivating awe improves wellbeing.
[6-min read] Q&A with Rachel Yehuda, Professor & Researcher
[3-min read] Psychedelic facilitators advise on dealing with uncomfortable insights.
[5-min read] New guidelines could improve rigor and reliability of psychedelic clinical trials.
[5-min read] Q&A with Hamilton Souther, Mystic & Technologist
[3-min read] Facilitators explain how to find your ideal psychedelic rhythm.
[5-min read] Long-awaited study of psilocybin in religious leaders is published despite federal violations.
